APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biolayer Interferometry (BLI)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biolayer Interferometry (BLI) Market Analysis and Forecast 2026-2032

3 May 2026229 pages

Choose your research edition.

Industry ResearchBiolayer Interferometry (BLI) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biolayer Interferometry (BLI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biolayer Interferometry (BLI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biolayer Interferometry (BLI) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biolayer Interferometry (BLI) Market Analysis and Forecast 2026-2032229 pages · $4,950 USD

Market perspective

The global Biolayer Interferometry (BLI) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biolayer Interferometry (BLI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biolayer Interferometry (BLI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biolayer Interferometry (BLI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biolayer Interferometry (BLI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biolayer Interferometry (BLI) include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biolayer Interferometry (BLI), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biolayer Interferometry (BLI), also provides the revenue of main regions and countries. Of the upcoming market potential for Biolayer Interferometry (BLI), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biolayer Interferometry (BLI) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biolayer Interferometry (BLI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biolayer Interferometry (BLI) revenue, projected growth trends, production technology, application and end-user industry.

Biolayer Interferometry (BLI) Segment by Company

Ichor Life Sciences, Inc

Creative BioMart

GenScript

ROCKLAND IMMUNOCHEMICALS, INC

BPS Bioscience, Inc

Creative Proteomics

Creative Biostructure

Profacgen

Creative Biolabs

Biocult

KMD Bioscience Co., Ltd

Biolayer Interferometry (BLI) Segment by Type

Affinity and Kinetic Analysis

Drug and Antibody Screening

Drug and Antibody Discovery

Protein Quantification

Others

Biolayer Interferometry (BLI) Segment by Application

Pharmaceutical Industry

Diagnostics

Biotechnology

Scientific Research

Others

Biolayer Interferometry (BLI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biolayer Interferometry (BLI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biolayer Interferometry (BLI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biolayer Interferometry (BLI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biolayer Interferometry (BLI) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biolayer Interferometry (BLI) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biolayer Interferometry (BLI) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Affinity and Kinetic Analysis Major Player Table 3. Drug and Antibody Screening Major Player Table 4. Drug and Antibody Discovery Major Player Table 5. Protein Quantification Major Player Table 6. Others Major Player Table 7. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharmaceutical Industry Major Player Table 9. Diagnostics Major Player Table 10. Biotechnology Major Player Table 11. Scientific Research Major Player Table 12. Others Major Player Table 13. Biolayer Interferometry (BLI) Industry Trends Table 14. Biolayer Interferometry (BLI) Industry Drivers Table 15. Biolayer Interferometry (BLI) Industry Opportunities and Challenges Table 16. Biolayer Interferometry (BLI) Industry Restraints Table 17. Global Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Biolayer Interferometry (BLI) Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Biolayer Interferometry (BLI) Market Share by Region (2021-2026) Table 20. Global Biolayer Interferometry (BLI) Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Biolayer Interferometry (BLI) Market Share by Region (2027-2032) Table 22. Global Biolayer Interferometry (BLI) Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2021-2026) Table 24. Global Biolayer Interferometry (BLI) Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Biolayer Interferometry (BLI) Key Players Headquarters & Area Served Table 26. Global Biolayer Interferometry (BLI) Players, Product Type & Application Table 27. Global Biolayer Interferometry (BLI) Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Biolayer Interferometry (BLI) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Biolayer Interferometry (BLI) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021-2026) Table 34. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2027-2032) Table 35. Global Biolayer Interferometry (BLI) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021-2026) Table 39. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2027-2032) Table 40. Ichor Life Sciences, Inc Company Information Table 41. Ichor Life Sciences, Inc Business Overview Table 42. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio Table 44. Ichor Life Sciences, Inc Recent Development Table 45. Creative BioMart Company Information Table 46. Creative BioMart Business Overview Table 47. Creative BioMart Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Creative BioMart Biolayer Interferometry (BLI) Product Portfolio Table 49. Creative BioMart Recent Development Table 50. GenScript Company Information Table 51. GenScript Business Overview Table 52. GenScript Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GenScript Biolayer Interferometry (BLI) Product Portfolio Table 54. GenScript Recent Development Table 55. ROCKLAND IMMUNOCHEMICALS, INC Company Information Table 56. ROCKLAND IMMUNOCHEMICALS, INC Business Overview Table 57. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio Table 59. ROCKLAND IMMUNOCHEMICALS, INC Recent Development Table 60. BPS Bioscience, Inc Company Information Table 61. BPS Bioscience, Inc Business Overview Table 62. BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio Table 64. BPS Bioscience, Inc Recent Development Table 65. Creative Proteomics Company Information Table 66. Creative Proteomics Business Overview Table 67. Creative Proteomics Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio Table 69. Creative Proteomics Recent Development Table 70. Creative Biostructure Company Information Table 71. Creative Biostructure Business Overview Table 72. Creative Biostructure Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio Table 74. Creative Biostructure Recent Development Table 75. Profacgen Company Information Table 76. Profacgen Business Overview Table 77. Profacgen Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Profacgen Biolayer Interferometry (BLI) Product Portfolio Table 79. Profacgen Recent Development Table 80. Creative Biolabs Company Information Table 81. Creative Biolabs Business Overview Table 82. Creative Biolabs Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio Table 84. Creative Biolabs Recent Development Table 85. Biocult Company Information Table 86. Biocult Business Overview Table 87. Biocult Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Biocult Biolayer Interferometry (BLI) Product Portfolio Table 89. Biocult Recent Development Table 90. KMD Bioscience Co., Ltd Company Information Table 91. KMD Bioscience Co., Ltd Business Overview Table 92. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio Table 94. KMD Bioscience Co., Ltd Recent Development Table 95. North America Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Biolayer Interferometry (BLI) Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Biolayer Interferometry (BLI) Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Biolayer Interferometry (BLI) Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Biolayer Interferometry (BLI) Revenue by Country (US$ Million) & (2027-2032) Table 109. China Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 110. China Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 111. China Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 112. China Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Biolayer Interferometry (BLI) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Biolayer Interferometry (BLI) Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Biolayer Interferometry (BLI) Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Biolayer Interferometry (BLI) Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Biolayer Interferometry (BLI) Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Biolayer Interferometry (BLI) Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Biolayer Interferometry (BLI) Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Biolayer Interferometry (BLI) Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Biolayer Interferometry (BLI) Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Biolayer Interferometry (BLI) Image Figure 2. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biolayer Interferometry (BLI) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Affinity and Kinetic Analysis Image Figure 5. Drug and Antibody Screening Image Figure 6. Drug and Antibody Discovery Image Figure 7. Protein Quantification Image Figure 8. Others Image Figure 9. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Biolayer Interferometry (BLI) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharmaceutical Industry Image Figure 12. Diagnostics Image Figure 13. Biotechnology Image Figure 14. Scientific Research Image Figure 15. Others Image Figure 16. Global Biolayer Interferometry (BLI) Market Size (US$ Million) & (2021-2032) Figure 17. Global Biolayer Interferometry (BLI) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Biolayer Interferometry (BLI) Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Biolayer Interferometry (BLI) Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Biolayer Interferometry (BLI) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biolayer Interferometry (BLI) Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021-2032) Figure 24. Global Biolayer Interferometry (BLI) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021-2032) Figure 27. North America Biolayer Interferometry (BLI) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032) Figure 29. North America Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032) Figure 30. North America Biolayer Interferometry (BLI) Revenue Share by Country (2021-2032) Figure 31. United States Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Biolayer Interferometry (BLI) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032) Figure 36. Europe Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032) Figure 37. Europe Biolayer Interferometry (BLI) Revenue Share by Country (2021-2032) Figure 38. Germany Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Biolayer Interferometry (BLI) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032) Figure 48. China Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032) Figure 49. Asia Biolayer Interferometry (BLI) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032) Figure 51. Asia Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032) Figure 52. Asia Biolayer Interferometry (BLI) Revenue Share by Region (2021-2032) Figure 53. Japan Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Biolayer Interferometry (BLI) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032) Figure 61. SAMEA Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032) Figure 62. SAMEA Biolayer Interferometry (BLI) Revenue Share by Country (2021-2032) Figure 63. Brazil Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Biolayer Interferometry (BLI) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Affinity and Kinetic Analysis
  • Drug and Antibody Screening
  • Drug and Antibody Discovery
  • Protein Quantification
  • Others
Applications
  • Pharmaceutical Industry
  • Diagnostics
  • Biotechnology
  • Scientific Research
  • Others
Companies covered
  • Ichor Life Sciences, Inc
  • Creative BioMart
  • GenScript
  • ROCKLAND IMMUNOCHEMICALS, INC
  • BPS Bioscience, Inc
  • Creative Proteomics
  • Creative Biostructure
  • Profacgen
  • Creative Biolabs
  • Biocult
  • KMD Bioscience Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biolayer Interferometry (BLI) Market by Type
  3. 1.2.1 Global Biolayer Interferometry (BLI) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Affinity and Kinetic Analysis
  5. 1.2.3 Drug and Antibody Screening
  6. 1.2.4 Drug and Antibody Discovery
  7. 1.2.5 Protein Quantification
  8. 1.2.6 Others
  9. 1.3 Biolayer Interferometry (BLI) Market by Application
  10. 1.3.1 Global Biolayer Interferometry (BLI) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical Industry
  12. 1.3.3 Diagnostics
  13. 1.3.4 Biotechnology
  14. 1.3.5 Scientific Research
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Biolayer Interferometry (BLI) Market Dynamics
  1. 2.1 Biolayer Interferometry (BLI) Industry Trends
  2. 2.2 Biolayer Interferometry (BLI) Industry Drivers
  3. 2.3 Biolayer Interferometry (BLI) Industry Opportunities and Challenges
  4. 2.4 Biolayer Interferometry (BLI) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biolayer Interferometry (BLI) Market Perspective (2021-2032)
  2. 3.2 Global Biolayer Interferometry (BLI) Growth Trends by Region
  3. 3.2.1 Global Biolayer Interferometry (BLI) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biolayer Interferometry (BLI) Market Size by Region (2021-2026)
  5. 3.2.3 Global Biolayer Interferometry (BLI) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biolayer Interferometry (BLI) Revenue by Players
  2. 4.1.1 Global Biolayer Interferometry (BLI) Revenue by Players (2021-2026)
  3. 4.1.2 Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biolayer Interferometry (BLI) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biolayer Interferometry (BLI) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biolayer Interferometry (BLI) Key Players Headquarters & Area Served
  7. 4.4 Global Biolayer Interferometry (BLI) Players, Product Type & Application
  8. 4.5 Global Biolayer Interferometry (BLI) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biolayer Interferometry (BLI) Market CR5 and HHI
  11. 4.6.3 2025 Biolayer Interferometry (BLI) Tier 1, Tier 2, and Tier 3
5 Biolayer Interferometry (BLI) Market Size by Type
  1. 5.1 Global Biolayer Interferometry (BLI) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 5.3 Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021-2032)
6 Biolayer Interferometry (BLI) Market Size by Application
  1. 6.1 Global Biolayer Interferometry (BLI) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  3. 6.3 Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Ichor Life Sciences, Inc
  2. 7.1.1 Ichor Life Sciences, Inc Company Information
  3. 7.1.2 Ichor Life Sciences, Inc Business Overview
  4. 7.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio
  6. 7.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 7.2 Creative BioMart
  8. 7.2.1 Creative BioMart Company Information
  9. 7.2.2 Creative BioMart Business Overview
  10. 7.2.3 Creative BioMart Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative BioMart Biolayer Interferometry (BLI) Product Portfolio
  12. 7.2.5 Creative BioMart Recent Developments
  13. 7.3 GenScript
  14. 7.3.1 GenScript Company Information
  15. 7.3.2 GenScript Business Overview
  16. 7.3.3 GenScript Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GenScript Biolayer Interferometry (BLI) Product Portfolio
  18. 7.3.5 GenScript Recent Developments
  19. 7.4 ROCKLAND IMMUNOCHEMICALS, INC
  20. 7.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Information
  21. 7.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
  22. 7.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio
  24. 7.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments
  25. 7.5 BPS Bioscience, Inc
  26. 7.5.1 BPS Bioscience, Inc Company Information
  27. 7.5.2 BPS Bioscience, Inc Business Overview
  28. 7.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio
  30. 7.5.5 BPS Bioscience, Inc Recent Developments
  31. 7.6 Creative Proteomics
  32. 7.6.1 Creative Proteomics Company Information
  33. 7.6.2 Creative Proteomics Business Overview
  34. 7.6.3 Creative Proteomics Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio
  36. 7.6.5 Creative Proteomics Recent Developments
  37. 7.7 Creative Biostructure
  38. 7.7.1 Creative Biostructure Company Information
  39. 7.7.2 Creative Biostructure Business Overview
  40. 7.7.3 Creative Biostructure Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio
  42. 7.7.5 Creative Biostructure Recent Developments
  43. 7.8 Profacgen
  44. 7.8.1 Profacgen Company Information
  45. 7.8.2 Profacgen Business Overview
  46. 7.8.3 Profacgen Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Profacgen Biolayer Interferometry (BLI) Product Portfolio
  48. 7.8.5 Profacgen Recent Developments
  49. 7.9 Creative Biolabs
  50. 7.9.1 Creative Biolabs Company Information
  51. 7.9.2 Creative Biolabs Business Overview
  52. 7.9.3 Creative Biolabs Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio
  54. 7.9.5 Creative Biolabs Recent Developments
  55. 7.10 Biocult
  56. 7.10.1 Biocult Company Information
  57. 7.10.2 Biocult Business Overview
  58. 7.10.3 Biocult Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Biocult Biolayer Interferometry (BLI) Product Portfolio
  60. 7.10.5 Biocult Recent Developments
  61. 7.11 KMD Bioscience Co., Ltd
  62. 7.11.1 KMD Bioscience Co., Ltd Company Information
  63. 7.11.2 KMD Bioscience Co., Ltd Business Overview
  64. 7.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio
  66. 7.11.5 KMD Bioscience Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Biolayer Interferometry (BLI) Revenue (2021-2032)
  2. 8.2 North America Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 8.2.1 North America Biolayer Interferometry (BLI) Revenue by Type (2021-2026)
  4. 8.2.2 North America Biolayer Interferometry (BLI) Revenue by Type (2027-2032)
  5. 8.3 North America Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032)
  6. 8.4 North America Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  7. 8.4.1 North America Biolayer Interferometry (BLI) Revenue by Application (2021-2026)
  8. 8.4.2 North America Biolayer Interferometry (BLI) Revenue by Application (2027-2032)
  9. 8.5 North America Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032)
  10. 8.6 North America Biolayer Interferometry (BLI) Revenue by Country
  11. 8.6.1 North America Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biolayer Interferometry (BLI) Revenue by Country (2021-2026)
  13. 8.6.3 North America Biolayer Interferometry (BLI) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biolayer Interferometry (BLI) Revenue (2021-2032)
  2. 9.2 Europe Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biolayer Interferometry (BLI) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biolayer Interferometry (BLI) Revenue by Type (2027-2032)
  5. 9.3 Europe Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biolayer Interferometry (BLI) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biolayer Interferometry (BLI) Revenue by Application (2027-2032)
  9. 9.5 Europe Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biolayer Interferometry (BLI) Revenue by Country
  11. 9.6.1 Europe Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biolayer Interferometry (BLI) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biolayer Interferometry (BLI) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biolayer Interferometry (BLI) Revenue (2021-2032)
  2. 10.2 China Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 10.2.1 China Biolayer Interferometry (BLI) Revenue by Type (2021-2026)
  4. 10.2.2 China Biolayer Interferometry (BLI) Revenue by Type (2027-2032)
  5. 10.3 China Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032)
  6. 10.4 China Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  7. 10.4.1 China Biolayer Interferometry (BLI) Revenue by Application (2021-2026)
  8. 10.4.2 China Biolayer Interferometry (BLI) Revenue by Application (2027-2032)
  9. 10.5 China Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biolayer Interferometry (BLI) Revenue (2021-2032)
  2. 11.2 Asia Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biolayer Interferometry (BLI) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biolayer Interferometry (BLI) Revenue by Type (2027-2032)
  5. 11.3 Asia Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biolayer Interferometry (BLI) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biolayer Interferometry (BLI) Revenue by Application (2027-2032)
  9. 11.5 Asia Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biolayer Interferometry (BLI) Revenue by Country
  11. 11.6.1 Asia Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biolayer Interferometry (BLI) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biolayer Interferometry (BLI) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biolayer Interferometry (BLI) Revenue (2021-2032)
  2. 12.2 SAMEA Biolayer Interferometry (BLI) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biolayer Interferometry (BLI) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biolayer Interferometry (BLI) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biolayer Interferometry (BLI) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biolayer Interferometry (BLI) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biolayer Interferometry (BLI) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biolayer Interferometry (BLI) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biolayer Interferometry (BLI) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biolayer Interferometry (BLI) Revenue by Country
  11. 12.6.1 SAMEA Biolayer Interferometry (BLI) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biolayer Interferometry (BLI) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biolayer Interferometry (BLI) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst